PubMed HealthSearch

PubMed · 7064059

Liver failure.

Abstract

Hepatic failure emerging in a patient after injury is generally manifested as cholestatic jaundice. It differs in several important respects from hepatic failure, as it is understood to present in alcoholic or posthepatitic patients. Sepsis is the etiology of the hepatic failure in the overwhelming majority of patients who die following posttraumatic organ failure. Therefore, aggressive attempts to localize and eradicate infected foci are the foundation of treatment. Exploratory laparotomy will be a necessary diagnostic and therapeutic maneuver in many of these patients and will yield a 50 per cent rate of improvement and survival of patients.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

L M Flint. 1982. Liver failure.. https://doi.org/10.1016/s0039-6109(16)42642-3

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Chronic cholestasis of infancy.

This article focuses on the few disorders that produce chronic cholestasis in infants and children. Cholestasis is defined, and a framework for thinking about pathophysiology is provided. Medical management is discussed in the context of the consequences and complications of chronic cholestasis. The limited differential for chronic cholestasis is discussed, and approaches to diagnosis and management of specific disorders are provided.

Cholestasis

Pancreatic cancer treatment in the U.S. veteran from 1987 to 1991: effect of tumor stage on survival.

To assess the outcomes after pancreatic cancer treatment in a nationwide hospital system, patients treated in Department of Veterans Affairs (DVA) hospitals from 1987 to 1991 were studied by tumor stage, the most significant reported influence on survival. Tumor registrars from DVA hospitals provided information that allowed TNM staging in 598 patients, and duration of survival from treatment to death was known in 96+% of cases. Survival was 9 months longer after 64 resections for stage I-II (localized) pancreatic cancer than after 149 other treatments (P < 0.05, ANOVA), but resection did not increase mean survival in 49 patients with stage III (lymph node metastases) disease. Twenty-one patients with ampullary, duodenal, bile duct, or cystic cancers had a significantly increased survival at any stage, but this may be due to the selection of sicker patients for nonoperative therapies.

Cholestasis